Bioavailability, Pharmacokinetics, and Analgesic Activity of Ketamine in Humans
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The pharmacokinetics of ketamine in analgesic doses after intravenous, intramuscular, and oral administration was investigated in healthy volunteers. Plasma ketamine concentration-time curves were fitted by a two-compartment open model with a terminal half-life of 186 min. Absorption after intramuscular injection was rapid and the bioavailability was 93%. However, only 17% of an oral dose was absorbed because of extensive first-pass metabolism. Simultaneous measurements of the elevation of pain threshold in an ischemic exercise test showed a marked effect for 15-60 min after intramuscular injection, but little or no effect after the oral solution. Pain threshold elevation occurred at plasma ketamine concentrations above 160 ng/ml.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Regarding elimination of ketamine and its metabolites, the elimination half-life is between two to four hours, varying slightly with the route of administration”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Clements et al., 1982
Citations
Cites
A Simplex Method for Function Minimization
Nelder, J. A., & Mead, R. (1965) · The Computer Journal · doi:10.1093/comjnl/7.4.308 · Cited by 28,905
TESTING FOR SERIAL CORRELATION IN LEAST SQUARES REGRESSION. II
DURBIN, J., & WATSON, G. S. (1951) · Biometrika · doi:10.1093/biomet/38.1-2.159 · Cited by 3,619
Drugs and the Pharmaceutical Sciences
(2010) · Drugs and the pharmaceutical sciences · doi:10.1201/ihcdruphasci · Cited by 586
New Method for Calculating the Intrinsic Absorption Rate of Drugs
Loo, J. C. K., & Riegelman, S. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600570602 · Cited by 466
PHARMACOKINETICS AND ANALGESIC EFFECTS OF I.M. AND ORAL KETAMINE
GRANT, I. S., NIMMO, W. S., & CLEMENTS, J. A. (1981) · British Journal of Anaesthesia · doi:10.1093/bja/53.8.805 · Cited by 355
Self-citationPHARMACOKINETICS AND ANALGESIC EFFECT OF KETAMINE IN MAN
CLEMENTS, J. A., & NIMMO, W. S. (1981) · British Journal of Anaesthesia · doi:10.1093/bja/53.1.27 · Cited by 322
Self-citationKETAMINE INFUSIONS: PHARMACOKINETICS AND CLINICAL EFFECTS
IDVALL, J., AHLGREN, I., ARONSEN, K. F., & STENBERG, P. (1979) · British Journal of Anaesthesia · doi:10.1093/bja/51.12.1167 · Cited by 306
Influence of Route of Administration on Drug Availability
Rowland, M. (1972) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600610111 · Cited by 264
Pedersen, P. V. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061732 · Cited by 219
Ottaway, J. H. (1973) · Biochemical Journal · doi:10.1042/bj1340729 · Cited by 101
Research works printed but not linked: 9
- Wieber, 1975, Anaesthetist, 24, 260
- Clausen, 1975, Med. J., 49, 1437
- Harrison, 1943, Proc. Assoc. Res. Nerv. Ment. Dis., 23, 154
- Walle, 1970, Acta Pharm. Suec., 7, 389
- Durbin, 1950, Biometrika, 37, 409
- Gibaldi, 1979, Vol. 1, 232
- Rowland, 1972, ibid, 61, 70
- Gibaldi, 1971, ibid., 60, 624
- Pang, 1978, ibid., 67, 703
Cited by
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
Yang, Y., Cui, Y., Sang, K., Dong, Y., Ni, Z., Ma, S., & Hu, H. (2018) · Nature · doi:10.1038/nature25509 · Cited by 1,036
Ketamine Pharmacology: An Update ( Pharmacodynamics and Molecular Aspects, Recent Findings )
Mion, G., & Villevieille, T. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12099 · Cited by 711
“The ketamine analgesic effect persists for steady-state plasma concentrations superior to 100–160 ng/ml [49] (about 0.”
BackgroundKetamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0383-6 · Cited by 672
“Following an intramuscular dose of 2–4 mg/kg, ketamine is rapidly absorbed and bioavailability is approximately 93 % [10, 11].”
Schwenk, E. S., Viscusi, E. R., Buvanendran, A., Hurley, R. W., Wasan, A. D., Narouze, S., Bhatia, A., Davis, F. N., Hooten, W. M., & Cohen, S. P. (2018) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000806 · Cited by 584
“Ketamine produces analgesia at plasma concentrations of 100 to 200 ng/mL, which represent a small fraction of plasma concentrations after general anesthesia doses (9000–25,000 ng/mL).(29,30) The common subanesthetic dose of ketamine used in clinical practice is intravenous (IV) 0.”
Metadata
- Authors
- Clements, J. A., Nimmo, W. S., & Grant, I. S.
- Affiliations
- Heriot-Watt University (GB)
- Western Infirmary (GB)
- Corresponding author
- Clements, J.A.
- ORCID
- Grant, I.S.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 1982-05
- Volume
- 71
- Issue
- 5
- Pages
- 539-542
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2094496261
- Cited by
- 420
- References
- 20
- Citations by year
- 2026: 20 · 2025: 25 · 2024: 17 · 2023: 20 · 2022: 34 · 2021: 17 · 2020: 50 · 2019: 11 · 2018: 20 · 2017: 13 · 2016: 20 · 2015: 16 · 2014: 21 · 2013: 16 · 2012: 10
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- ketamine, pharmacokinetics, bioavailability, analgesia, pain threshold, first-pass metabolism, intramuscular injection, oral administration, intravenous administration, two-compartment model, terminal half-life
- MeSH terms
- Administration, Oral, Adult, Analgesics, Biological Availability, Physical Exertion, Humans, Injections, Intramuscular, Injections, Intravenous, Ketamine, Kinetics, Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bioavailability, Pharmacokinetics, and Analgesic Activity of Ketamine in Humans. https://app.cochat.ai/papers/10.1002/jps.2600710516
- The paper
- Clements, J. A., Nimmo, W. S., & Grant, I. S. (1982). Bioavailability, Pharmacokinetics, and Analgesic Activity of Ketamine in Humans. Journal of Pharmaceutical Sciences. https://doi.org/10.1002/jps.2600710516
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.